{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,12,19]],"date-time":"2023-12-19T19:40:58Z","timestamp":1703014858773},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2019,5,3]],"date-time":"2019-05-03T00:00:00Z","timestamp":1556841600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Klin Intensivmed Notfmed"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1007\/s00063-019-0581-8","type":"journal-article","created":{"date-parts":[[2019,5,3]],"date-time":"2019-05-03T10:16:37Z","timestamp":1556878597000},"page":"475-484","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Diagnose und Behandlung des Status epilepticus auf der Intensivstation"],"prefix":"10.1007","volume":"114","author":[{"given":"W.","family":"M\u00fcllges","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,5,3]]},"reference":[{"key":"581_CR1","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1111\/j.1528-1167.2009.02410.x","volume":"51","author":"O Veran","year":"2010","unstructured":"Veran O, Kahane P, Thomas P et\u00a0al (2010) De novo epileptic confusion in the elderly. Epilepsia 51:1030\u20131035","journal-title":"Epilepsia"},{"key":"581_CR2","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.yebeh.2015.05.005","volume":"49","author":"E Trinka","year":"2015","unstructured":"Trinka E, Leitinger M (2015) Which EEG patterns in coma are nonconvulsive status epilepticus? Epilepsy Behav 49:203\u2013222","journal-title":"Epilepsy Behav"},{"key":"581_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1528-1167.2011.03221.x","volume":"S8","author":"SE Shorvon","year":"2011","unstructured":"Shorvon SE, Trinka E (2011) Proceedings of the 3rd London-Innsbruck colloquium on status epilepticus. Epilepsia S8:1\u201385","journal-title":"Epilepsia"},{"key":"581_CR4","first-page":"1362","volume":"21","author":"SE Hocker","year":"2015","unstructured":"Hocker SE (2015) Status epilepticus. Continuum (N Y) 21:1362\u20131383","journal-title":"Continuum (N Y)"},{"key":"581_CR5","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1136\/jnnp.2004.041947","volume":"76","author":"M Holtkamp","year":"2005","unstructured":"Holtkamp M, Othman J, Buchheim K, Meierkord H (2005) Predictors and prognosis of refractory status epilepticus in a\u00a0neurological intensive care unit. J\u00a0Neurol Neurosurg Psychiatr 76:534\u2013539","journal-title":"J Neurol Neurosurg Psychiatr"},{"key":"581_CR6","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1001\/archneur.59.2.205","volume":"59","author":"SA Mayer","year":"2002","unstructured":"Mayer SA, Claassen J, Lokin J et\u00a0al (2002) Refractory status epilepticus: Frequency, risk factors, and impact on outcome. Arch Neurol 59:205\u2013210","journal-title":"Arch Neurol"},{"key":"581_CR7","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1001\/jamaneurol.2013.578","volume":"70","author":"SE Hocker","year":"2013","unstructured":"Hocker SE, Britton JW, Mandrekar JN et\u00a0al (2013) Predictors of outcome in refractory status epilepticus. JAMA Neurol 70:72\u201377","journal-title":"JAMA Neurol"},{"key":"581_CR8","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.seizure.2008.06.013","volume":"18","author":"R Alroughani","year":"2009","unstructured":"Alroughani R, Javidan M, Quasem A, Alotaibi N (2009) Non-convulsive status epilepticus: The rate of occurrence in a\u00a0general hospital. Seizure 18:38\u201342","journal-title":"Seizure"},{"key":"581_CR9","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.yebeh.2015.04.047","volume":"49","author":"JA Gorter","year":"2015","unstructured":"Gorter JA, van Vliet EA, Aronica E (2015) Status epilepticus, blood brain barrier disruption, inflammation, and epileptogenesis. Epilepsia Behav 49:13\u201318","journal-title":"Epilepsia Behav"},{"key":"581_CR10","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1111\/j.1528-1167.2010.02688.x","volume":"51","author":"A Aranda","year":"2010","unstructured":"Aranda A, Foucard G, Ducasse JL et\u00a0al (2010) Generalized convulsive status epilepticus management in adults. Epilepsia 51:2159\u20132167","journal-title":"Epilepsia"},{"key":"581_CR11","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s11940-016-0394-5","volume":"18","author":"EH Grover","year":"2016","unstructured":"Grover EH, Nazzal Y, Hirsch LJ (2016) Treatment of convulsive status epilepticus. Curr Treat Options Neurol 18:11","journal-title":"Curr Treat Options Neurol"},{"issue":"09","key":"581_CR12","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1055\/s-0043-110140","volume":"44","author":"A Strzelczyk","year":"2017","unstructured":"Strzelczyk A, Kay L, Kellinghaus C et\u00a0al (2017) Konzepte zur pr\u00e4hospitalen und initialen intrahospitalen Therapie des Status epilepticus. Aktuelle Neurol 44(09):637\u2013644","journal-title":"Aktuelle Neurol"},{"key":"581_CR13","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s12028-012-9695-z","volume":"17","author":"GM Brophy","year":"2012","unstructured":"Brophy GM, Bell R, Claassen J et\u00a0al (2012) Guidelines for the evaluation and management of status epilepticus. Neurocrit Care 17:3\u201323","journal-title":"Neurocrit Care"},{"key":"581_CR14","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1056\/NEJM199809173391202","volume":"339","author":"DM Treiman","year":"1998","unstructured":"Treiman DM, Meyers PD, Walton NY et\u00a0al (1998) A comparison of four treatments for generalized status epilepticus. N\u00a0Eng J Med 339:792\u2013798","journal-title":"N Eng J Med"},{"key":"581_CR15","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1097\/TME.0000000000000064","volume":"37","author":"R Rogalski","year":"2015","unstructured":"Rogalski R, Rogalski A (2015) Benzodiazepine selection in the management of status epilepticus: A\u00a0review. Adv Emerg Nurs\u00a0J 37:83\u201394","journal-title":"Adv Emerg Nurs J"},{"key":"581_CR16","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1056\/NEJMoa002141","volume":"345","author":"BK Alldredge","year":"2001","unstructured":"Alldredge BK, Gelb AM, Isaacs SM et al (2001) A comparison of lorazepam, diazepam, and placebo for the treatment of ot-of-hospital status epilepticus. N\u00a0Eng J Med 345:631\u2013637","journal-title":"N Eng J Med"},{"key":"581_CR17","doi-asserted-by":"publisher","first-page":"39","DOI":"10.4065\/76.1.39","volume":"76","author":"GD Cascino","year":"2001","unstructured":"Cascino GD, Hessdorfer D, Logroscino G, Hauser WA (2001) Treatment of nonfebrile status epilepticus in Rochester. Mayo Clin Proc 76:39\u201341","journal-title":"Mayo Clin Proc"},{"key":"581_CR18","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.seizure.2007.04.012","volume":"16","author":"P Agarwal","year":"2007","unstructured":"Agarwal P, Kumar N, Chandra R et\u00a0al (2007) Randomized study of intravenous valproate and phenytoin in status epilepticus. Seizure 16:527\u2013532","journal-title":"Seizure"},{"key":"581_CR19","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.eplepsyres.2015.04.003","volume":"114","author":"MM Atmaca","year":"2015","unstructured":"Atmaca MM, Orhan EK, Bebek N, Gurses C (2015) Intravenous levetiracetam treatment in status epilepticus. Epilepsia Res 114:13\u201322","journal-title":"Epilepsia Res"},{"key":"581_CR20","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.seizure.2017.02.015","volume":"47","author":"G Zaccara","year":"2017","unstructured":"Zaccara G, Giamari G, Oggioni R et\u00a0al (2017) Challenges in the treatment of convulsive status epilepticus. Seizure 47:17\u201324","journal-title":"Seizure"},{"key":"581_CR21","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1212\/WNL.0000000000000009","volume":"82","author":"R Sutter","year":"2014","unstructured":"Sutter R, Marsch S, Fuhr P et\u00a0al (2014) Anesthetic drugs in status epilepticus: Risk or rescue? Neurology 82:656\u2013664","journal-title":"Neurology"},{"key":"581_CR22","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1055\/s-0043-110223","volume":"44","author":"S Gollwitzer","year":"2017","unstructured":"Gollwitzer S, Hamer HM (2017) Therapie und Prognose des refrakt\u00e4ren und super-refrakt\u00e4ren Status epilepticus. Aktuelle Neurol 44:662\u2013668","journal-title":"Aktuelle Neurol"},{"key":"581_CR23","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1017\/cjn.2014.121","volume":"42","author":"FA Zeiler","year":"2015","unstructured":"Zeiler FA, Zeiler KJ, Teilelbaum J et\u00a0al (2015) Modern inhalational anesthetics for refractory status epilepticus. Can J Neurol Sci 42:106\u2013115","journal-title":"Can J Neurol Sci"},{"key":"581_CR24","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1017\/cjn.2015.31","volume":"42","author":"FA Zeiler","year":"2015","unstructured":"Zeiler FA, Zeiler KJ, Teitelbaum J et\u00a0al (2015) Therapeutic hypothermia for refractory status epilepticus. Can J Neurol Sci 42:221\u2013229","journal-title":"Can J Neurol Sci"},{"key":"581_CR25","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1056\/NEJMoa1107494","volume":"366","author":"R Silbergleit","year":"2012","unstructured":"Silbergleit R, Dukalski V, Lowenstein D et\u00a0al (2012) Intramuscular versus intravenous therapy for prehospital status epilepticus. N\u00a0Eng J Med 366:591\u2013600","journal-title":"N Eng J Med"}],"container-title":["Medizinische Klinik - Intensivmedizin und Notfallmedizin"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00063-019-0581-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00063-019-0581-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00063-019-0581-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T23:17:16Z","timestamp":1588375036000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00063-019-0581-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,3]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["581"],"URL":"https:\/\/doi.org\/10.1007\/s00063-019-0581-8","relation":{},"ISSN":["2193-6218","2193-6226"],"issn-type":[{"value":"2193-6218","type":"print"},{"value":"2193-6226","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,3]]},"assertion":[{"value":"4 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"Gem\u00e4\u00df den Richtlinien des Springer Medizin Verlags werden Autoren und wissenschaftliche Leitung im Rahmen der Manuskripterstellung und Manuskriptfreigabe aufgefordert, eine vollst\u00e4ndige Erkl\u00e4rung zu ihren finanziellen und nichtfinanziellen Interessen abzugeben.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"W.\u00a0M\u00fcllges: finanzielle Interessen: Referentenhonorar oder Kostenerstattung als passiver Teilnehmer (Erstattung von Reise- oder \u00dcbernachtungskosten sowie Teilnahmegeb\u00fchren): Alexion Pharma | Bayer Pharma | Boehringer Ingelheim | KoMed GbR | medizinische Fachgesellschaften | diverse Kliniken: Rednerhonorare und Reisekostenerstattung \u2022 nichtfinanzielle Interessen: berufliche T\u00e4tigkeit, Mitgliedschaften, Position in wissenschaftlichen Gesellschaften, Berufsverb\u00e4nden sowie hier relevanten Vereinigungen: bayerischer Beamter | leitender Oberarzt Universit\u00e4tsklinikum | Mitgliedschaften: Deutsche Gesellschaft f\u00fcr Neurologie, Deutsche Gesellschaft f\u00fcr Neurointensiv- und Notfallmedizin, Deutsche Gesellschaft f\u00fcr Klinische Neurophysiologie und funktionelle Bildgebung, Deutsche Gesellschaft f\u00fcr Ultraschall in der Medizin, \u00c4rztliche Arbeitsgemeinschaft zur F\u00f6rderung der Geriatrie in Bayern.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Autoren"}},{"value":"Die vollst\u00e4ndige Erkl\u00e4rung zum Interessenkonflikt der wissenschaftlichen Leitung finden Sie am Kurs der zertifizierten Fortbildung auf ExternalRef removed.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Wissenschaftliche Leitung"}},{"value":"erkl\u00e4rt, dass f\u00fcr die Publikation dieser CME-Fortbildung keine Sponsorengelder an den Verlag flie\u00dfen.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}}]}}